These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26666938)

  • 41. Characteristics and costs of carbapenemase-producing enterobacteria carriers (2012/2013).
    Daroukh A; Delaunay C; Bigot S; Ceci JM; Siddhoun N; Bukreyeva I; Raisin J; Porcheret H; Maisonneuve L; Bouldouyre MA
    Med Mal Infect; 2014 Jul; 44(7):321-6. PubMed ID: 25022890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors.
    Hamprecht A; Rohde AM; Behnke M; Feihl S; Gastmeier P; Gebhardt F; Kern WV; Knobloch JK; Mischnik A; Obermann B; Querbach C; Peter S; Schneider C; Schröder W; Schwab F; Tacconelli E; Wiese-Posselt M; Wille T; Willmann M; Seifert H; Zweigner J;
    J Antimicrob Chemother; 2016 Oct; 71(10):2957-63. PubMed ID: 27317445
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae.
    Tamma PD; Girdwood SC; Gopaul R; Tekle T; Roberts AA; Harris AD; Cosgrove SE; Carroll KC
    Clin Infect Dis; 2013 Sep; 57(6):781-8. PubMed ID: 23759352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical features of nosocomial infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units.
    Chiu S; Huang YC; Lien RI; Chou YH; Lin TY
    Acta Paediatr; 2005 Nov; 94(11):1644-9. PubMed ID: 16303704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge.
    Birgand G; Armand-Lefevre L; Lolom I; Ruppe E; Andremont A; Lucet JC
    Am J Infect Control; 2013 May; 41(5):443-7. PubMed ID: 22998785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.
    Logan LK; Renschler JP; Gandra S; Weinstein RA; Laxminarayan R; ;
    Emerg Infect Dis; 2015 Nov; 21(11):2014-21. PubMed ID: 26486124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of Persistent Carbapenem-Resistant Enterobacteriaceae Carriage upon Readmission and Score Development.
    Ciobotaro P; Flaks-Manov N; Oved M; Schattner A; Hoshen M; Ben-Yosef E; Balicer RD; Zimhony O
    Infect Control Hosp Epidemiol; 2016 Feb; 37(2):188-96. PubMed ID: 26750741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
    Asensio Á; Cantero M; Shaw E; Vergara-López S
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():61-6. PubMed ID: 25542054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units.
    Thiébaut AC; Arlet G; Andremont A; Papy E; Sollet JP; Bernède-Bauduin C; Guillemot D; Schlemmer B;
    J Antimicrob Chemother; 2012 Jun; 67(6):1525-36. PubMed ID: 22441577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae.
    Barbier F; Bailly S; Schwebel C; Papazian L; Azoulay É; Kallel H; Siami S; Argaud L; Marcotte G; Misset B; Reignier J; Darmon M; Zahar JR; Goldgran-Toledano D; de Montmollin É; Souweine B; Mourvillier B; Timsit JF;
    Intensive Care Med; 2018 May; 44(5):616-626. PubMed ID: 29663045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization.
    Denkel LA; Gastmeier P; Leistner R
    Infection; 2014 Oct; 42(5):945-6. PubMed ID: 25160041
    [No Abstract]   [Full Text] [Related]  

  • 52. Characterization of plasmid-mediated β-lactamases in fecal colonizing patients in the hospital and community setting in Spain.
    Garrido A; Seral C; Gude MJ; Casado C; González-Domínguez M; Sáenz Y; Castillo FJ
    Microb Drug Resist; 2014 Aug; 20(4):301-4. PubMed ID: 24328895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carbapenemase-producing Enterobacteriaceae: a call for action!
    Nordmann P; Cornaglia G
    Clin Microbiol Infect; 2012 May; 18(5):411-2. PubMed ID: 22507108
    [No Abstract]   [Full Text] [Related]  

  • 54. Extended-spectrum beta-lactamase-producing Enterobacteriacae: unexpected low prevalence of carriage in elderly French residents.
    Bertrand X; Amara M; Sauget M; Clément MC; Talon D; Domelier-Valentin AS; Quentin R; van der Mee-Marquet N;
    Age Ageing; 2012 Mar; 41(2):233-7. PubMed ID: 22345296
    [No Abstract]   [Full Text] [Related]  

  • 55. Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study.
    Teo J; Cai Y; Tang S; Lee W; Tan TY; Tan TT; Kwa AL
    PLoS One; 2012; 7(3):e34254. PubMed ID: 22461908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of and risk factors associated with faecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in rural Thai communities.
    Luvsansharav UO; Hirai I; Nakata A; Imura K; Yamauchi K; Niki M; Komalamisra C; Kusolsuk T; Yamamoto Y
    J Antimicrob Chemother; 2012 Jul; 67(7):1769-74. PubMed ID: 22514260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarity.
    Conen A; Frei R; Adler H; Dangel M; Fux CA; Widmer AF
    PLoS One; 2015; 10(3):e0120688. PubMed ID: 25803720
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Therapeutic options for carbapenemase-producing Enterobacteriaceae].
    Salgado P; Gilsanz F; Maseda E
    Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():12-5. PubMed ID: 26365727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors for colonization with third-generation cephalosporin-resistant enterobacteriaceae.
    Wendt C; Lin D; von Baum H
    Infection; 2005 Oct; 33(5-6):327-32. PubMed ID: 16258862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extended-spectrum beta-lactamase producing Enterobacteriaceae in the intensive care unit: persistent issues to understand the transition from colonization to infection.
    Vodovar D; Mégarbane B
    Infection; 2014 Oct; 42(5):943-4. PubMed ID: 25168264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.